One Global Service Provider Limited (BOM:514330)
750.15
+30.50 (4.24%)
At close: Feb 13, 2026
BOM:514330 Market Cap
BOM:514330 has a market cap or net worth of 14.66 billion as of February 13, 2026. Its market cap has increased by 588.73% in one year.
Market Cap
14.66B
Enterprise Value
14.55B
Revenue
4.45B
Ranking
n/a
PE Ratio
34.76
Stock Price
750.15
Market Cap Chart
Since April 10, 2014, BOM:514330's market cap has increased from 71.05M to 14.66B, an increase of 20,534.47%. That is a compound annual growth rate of 56.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 14.66B | 17.85% |
| Dec 31, 2025 | 12.44B | 428.27% |
| Dec 31, 2024 | 2.35B | 709.60% |
| Dec 29, 2023 | 290.87M | 17.98% |
| Dec 30, 2022 | 246.53M | 66.03% |
| Dec 31, 2021 | 148.49M | 1,061.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thyrocare Technologies | 64.25B |
| Chandan Healthcare | 7.25B |
| Star Imaging and Path Lab | 1.38B |
| Modern Diagnostic & Research Centre | 1.19B |
| Invicta Diagnostic | 868.09M |
| Aspira Pathlab & Diagnostics | 662.77M |
| Nidan Laboratories and Healthcare | 248.81M |
| Family Care Hospitals | 193.37M |